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Abstract 
Background: The genetic contribution to complex diseases or traits, including cardio‑metabolic traits, has been 
elucidated recently by large‑scale genome‑wide association studies. These genome‑wide association studies have 
indicated that most pleiotropic loci contain genes associated with lipids. Clinically, lipid related abnormalities are 
strongly associated with other diseases such as type 2 diabetes, coronary artery disease and hypertension. The aim of 
this study was to evaluate the shared genetic background of lipids and other cardio‑metabolic traits.
Methods: We conducted meta‑analyses of the association between 157 published lipid‑associated loci and 10 car‑
dio‑metabolic traits in 14,028 Korean individuals genotyped using the Exome chip (Illumina HumanExome BeadChip). 
We also examined whether the pleiotropic effects of such loci constituted independent (i.e., biological) pleiotropy or 
mediated pleiotropy in these metabolic pathways.
Results: Eighteen lipid‑associated loci were significantly associated with one of six cardio‑metabolic traits after 
correction for multiple testing (P < 3.70 × 10−4). Region 12q24.12 had pleiotropic effects on fasting plasma glucose, 
blood pressure and obesity‑related traits (body mass index and waist‑hip ratio) independent of its effects on the lipid 
profile. Lipid risk scores, calculated according to whether or not subjects carried the risk allele for lipid traits, were 
significantly associated with fasting plasma glucose, blood pressure and obesity‑related traits.
Conclusions: The 12q24.12 region showed ethnic‑specific genetic pleiotropy among cardio‑metabolic traits in this 
study. Our findings may help to account for molecular mechanisms based on shared genetic background underlying 
not only dyslipidemia, but also cardiovascular disease and type 2 diabetes.
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Background
The etiology of cardiovascular disease (CVD) is complex, 
as both genetic and environmental factors contribute 
[1]. Common risk factors for CVD are cardio-metabolic 
traits such as lipids, blood pressure, obesity and diabe-
tes [2]. Of these, lipid-related abnormalities are strongly 
associated with type 2 diabetes (T2D)-related traits and 
hypertension [3]. For example, treatment of dyslipidemia 
can reduce the incidence of T2D [4], and circulating lev-
els of triglycerides (TG) and high-density lipoprotein 
(HDL) cholesterol are predictors of T2D [3]. However, 
although there are strong correlations between lipid-
related abnormalities and cardio-metabolic traits at the 
clinical level, the genetic and molecular mechanisms 
underlying the link between lipids and other cardio-met-
abolic traits remain unclear.
Genetic contributions to complex diseases or traits, 
including cardio-metabolic traits, have been analyzed by 
large-scale genome-wide association studies (GWASs) 
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[5–7]. To date, more than 157 loci have been associated 
with lipids [5]. Some of these loci are pleiotropic, that 
is, they also showed significant association with other 
cardio-metabolic traits [8]. The forms of pleiotropy are 
important to distinguish because they have different 
implications for disease risk and pathogenesis. Independ-
ent pleiotropy is considered as genuine pleiotropy, and 
refers to a genetic variant that affects more than one trait 
independently [9]. In contrast, mediated pleiotropy exists 
when one genetic variant has an effect on a trait that in 
turn affects another trait [10].
In this study, we aimed to examine the pleiotropic 
effects of published lipid-associated loci on 10 cardio-
metabolic traits in a Korean population using data from 
14,028 individuals directly genotyped by the Exome chip 
(Illumina HumanExome BeadChip). We also explored 
whether or not the observed pleiotropic associations 
were independent or mediated, and tested the hypoth-
esis that the effects of associations between lipid loci and 
other cardio-metabolic traits were controlled by lipids. 
By making lipid risk scores, we examined the cumula-
tive genetic effect of lipid-associated loci on other car-
dio-metabolic traits. Our results suggest the presence of 
shared genetic backgrounds and biological pathways for 
lipids and other risk factors for CVD.
Methods
Study participants
We performed Exome chip genotyping of 14,616 study 
participants from three population-based cohorts that 
are comprised in the Korean Genome Epidemiology 
Study (KoGES). We selected 7981 participants from the 
Ansung and Ansan population-based cohort (the Korea 
Association REsource (KARE) project), 3448 participants 
from the Health Examinee (HEXA) cohort and 3187 
participants from Cardio Vascular Disease Association 
Study (CAVAS). All participants were aged between 40 
and 69  years. More detailed descriptions of these three 
cohorts are available in published articles [11–13]. All 
participants provided written informed consent, and this 
study was approved by the ethical committee of our insti-
tute (Korea Centers for Disease Control and Prevention 
Institutional Review Board).
Phenotype determination
Blood levels of glycemic traits [fasting plasma glu-
cose (FPG), glycated hemoglobin (HbA1c)] and lipids 
[TG, total cholesterol (TC), and HDL] were meas-
ured in plasma (FPG), whole blood (HbA1c) and serum 
(lipids), respectively, using standard enzymatic methods 
from fasting-individuals. If the TG level was  <400  mg/
dl, the concentration of low-density lipoprotein (LDL) 
cholesterol was calculated using Friedewald’s formula 
[14]. Blood pressure (BP) was measured using a stand-
ard mercury sphygmomanometer after participants had 
been in a sitting position for at least 5 min. The mean of 
two measures (left and right arm) was taken as the BP. 
If participants were taking antihypertensive agents, BP 
values were adjusted for analyses by adding 10 mmHg to 
systolic BP (SBP) and 5 mmHg to diastolic BP (DBP) [7]. 
Body mass index (BMI) and waist-hip ratio (WHR) were 
defined as weight (in kilograms) divided by the square of 
height (in meters) and the ratio of waist to hip circumfer-
ences (in centimeters), respectively.
Individuals taking lipid lowering or anti-diabetes 
medication and individuals with FPG ≥  126  mg/dl and 
HbA1c  ≥  6.5  % were excluded from the analyses to 
obtain only non-diabetic individuals.
Exome chip
The Illumina HumanExome BeadChip is a genotyping 
array that includes variants represented by  ~250,000 
single nucleotide polymorphisms (SNPs) selected from 
exome and whole-genome sequences in  ~12,000 indi-
viduals [15]. This chip is focused on protein-altering 
variants (non-synonymous, stop and splice variants) and 
represents diverse populations and multiple complex 
traits [16, 17]. More detailed explanations about the con-
tents of the Exome chip can be found at the Exome chip 
design web page (http://genome.sph.umich.edu/wiki/
Exome_Chip_Design).
Genotyping and quality control
All 14,616 study participants were genotyped using 
the Illumina HumanExome BeadChip v1.1 (vari-
ants  =  242,901 SNPs). For genotype calling, each 
genotype was automatically clustered by the Illumina 
GenomeStudio v2011.1 software [18]. To improve the 
accuracy of variant calling, manual re-clustering and 
visual inspection were performed for genotypes based 
on the CHARGE clustering method [15]. After genotype 
calling, variants with completely missing (n  =  1431), 
monomorphic SNPs (n  =  162,803), Hardy–Weinberg 
equilibrium values of P < 1.0 × 10−6 (n = 1184) or geno-
type call rates of < 0.95 (n = 11) were excluded for qual-
ity control. Samples with a genotype call rate of < 99 % 
(n = 43), sex discrepancy (n = 51) or cryptic relatedness 
(n = 487), and withdrawal of participation (n = 7) were 
also removed for sample quality control.
After genotype and sample quality control, 77,472 
SNPs and 14,028 samples (7524 from KARE, 3436 from 
HEXA and 3068 from CAVAS) were available for further 
analyses. The number of SNPs with different minor allele 
frequencies is summarized in Additional file 1: Table S1.
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Selection of lipid‑associated SNPs for analyses
We focused on 157 loci that have been identified previ-
ously in large GWAS on lipids with genome-wide sig-
nificance (P  <  5  ×  10−8) [5]. Different lipids can have 
different best-associated SNPs in the same locus. After 
selection of the most strongly associated SNPs for each 
locus, 157 regions were mapped to 129 genes and 135 
SNPs [minor allele frequency (MAF) > 0.001, equivalent 
to a minor allele count ≥ 5 in each cohort].
Calculation of lipid risk score
To test the combined effects of lipid SNPs on other 
cardio-metabolic traits, we calculated two types of risk 
score, an unweighted risk score and a weighted risk 
score, for each SNP and each individual based on 49 
lipid-related SNPs that were replicated in this study. The 
list of SNPs is provided in Additional file  1: Table S3. 
The unweighted risk score was determined as the total 
number of risk alleles per individual, and the weighted 
risk score was calculated by weighting the risk alleles by 
their estimated effect size based on our data in this study 
[19]. Associations between lipid risk scores and cardio-
metabolic traits were evaluated based on a linear regres-
sion model using the R program (version 2.15.3; http://
www.r-project.org/). In this program, a linear model 
(function “lm” in the “stats” package) is constructed that 
includes variables such as lipid risk scores and cardio-
metabolic traits. For example, when we choose a model 
with three variables, the script is as follows;  >  fit  <− 
lm (y  ~  x1  +  x2  +  x3, data  =  riskscore),  >  summary 
(fit). Age, sex and lipids (TG, TC, LDL and HDL) were 
included in the analyses as covariates.
Statistical analyses
Single-variant association analysis was conducted 
between 135 SNPs and 10 cardio-metabolic traits (TG, 
TC, LDL, HDL, SBP, DBP, FPG, HbA1c, BMI and WHR) 
using a linear regression model via EPACTS v3.2.4 (http://
genome.sph.umich.edu/wiki/EPACTS) and PLINK 1.07 
(http://pngu.mgh.harvard.edu/~purcell/plink/) programs 
[20]. The main command of association analysis is “--test 
q.linear” and “--linear” to each program, respectively. To 
address the issue of multiple testing, a robust threshold 
of association significance (⍺  =  0.05/135 for each trait, 
P < 3.7 × 10−4) was used based on the Bonferroni correc-
tion. Phenotypes used in the analyses were approximately 
normally distributed, and age and sex were incorporated 
into the analyses as covariates. Meta-analyses of asso-
ciation results from each cohort were performed with 
the inverse variance method using the METAL program 
(http://genome.sph.umich.edu/wiki/METAL) [21].
To evaluate and clarify the type of pleiotropy (inde-
pendent or mediated) for three pleiotropic SNPs located 
on region 12q24.12, additional analyses were performed 
including adjustment of lipids (TC, TG, LDL and HDL) 
for other cardio-metabolic traits to examine whether 
or not any association occurred independently of lipids 
effects.
Protein–protein interactions
To search for functional interactions among genes, pro-
tein–protein interactions were performed using Wiki-Pi 
(http://severus.dbmi.pitt.edu/wiki-pi/) [22]. This tool 
provides information about one or both proteins in the 
interaction based on automatically updated annota-
tions of individual proteins from databases such as Gene 
Ontology, Kyoto Encyclopedia of Genes and Genomes, 
REACTOME, Pubmed2ENSEMBL and DrugBank.
Results
One hundred and fifty-seven lipid-associated loci, map-
ping to 129 genes and 135 SNPs (MAF > 0.001, equiva-
lent to a minor allele count ≥ 5) in our directly genotyped 
Exome chip data, were selected for analysis. All loci had a 
genome-wide significance P value (P < 5 × 10−8) accord-
ing to the Global Lipids Genetics Consortium [5]. The 
associations between each of the 135 SNPs and each of 
the 10 cardio-metabolic traits (TG, TC, HDL, LDL, SBP, 
DBP, FPG, HbA1c, BMI and WHR) were examined in 
14,028 Korean individuals from three cohorts based on 
Exome chip genotyping. Baseline characteristics of the 
study participants are summarized in Additional file  1: 
Table S2.
Genetic effects of previously implicated lipid‑associated 
SNPs
In the meta-analyses, 49 loci with new lead SNPs were 
significantly associated with one of four lipid traits 
(10 loci associated with TC, 11 with TG, 14 with HDL 
and 14 with LDL) after correction for multiple test-
ing (P < 3.70 × 10−4) (Additional file 1: Table S3). Most 
signals were associated with two or more lipid traits. 
The overlap of loci associated with different lipid traits 
is shown in Fig.  1. Among the 49 replicated SNPs, 22 
(45  %) were located in exonic regions and, of these, 18 
(82 %) were non-synonymous variants. Several non-syn-
onymous variants, which were located on PCSK9, CETP 
and APOA1 associated with TC or HDL and were novel 
protein-coding variants that had not been revealed in the 
same loci in previous studies.
Association between lipid‑associated SNPs and other 
cardio‑metabolic traits
Eighteen out of 135 SNPs were associated with other 
cardio-metabolic traits such as FPG, HbA1c, BMI, 
WHR, SBP and DBP after correction for multiple testing 
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(P  <  3.70  ×  10−4) (Table  1; Fig.  2). Our findings repli-
cated those of previous GWASs for five genes (GCKR, 
FADS1 and FADS2 for FPG, HFE for HbA1c and FTO for 
BMI) and also identified novel associations for 13 genes 
(three for FPG, four for WHR, three for SBP and three 
for DBP). Three associations were observed with one or 
more of four cardio-metabolic traits (FPG, WHR, SBP 
and DBP) within the genes BRAP, ACAD10 and ALDH2 
in the 12q24.12 region (Table  1; Fig.  2). These associa-
tions had not been reported in previous GWASs. The 
three SNPs were composed of two non-synonymous and 
one intronic variant and had same direction of effect for 
each trait. All three SNPs showed monomorphic ethnic 
differences in allele frequency from European and South 
Asian descent in comparison with allele frequency from 
our data (Korean individuals, average MAF  =  0.161) 
and East Asian descent (average MAF  =  0.175; calcu-
lated using data from the 1000 Genomes Project, http://
www.1000genomes.org/) (Additional file 1: Table S4).
The pleiotropic effect of SNPs in region 12q24.12
The pleiotropic effect of region 12q24.12 was identi-
fied for three SNPs (rs3782886 on BRAP, rs11066015 
on ACAD10 and rs671 on ALDH2) on lipids and other 
cardio-metabolic traits (Table 2). These SNPs were asso-
ciated with three lipid traits (TG, HDL and LDL), SBP, 
DBP, FPG, BMI and WHR (P < 0.05) and had the same 
direction of allelic effect for all cardio-metabolic traits 
(the linkage disequilibrium of these SNPs in our data, 
r2  =  0.988 between rs671 and rs11066015, r2  =  0.926 
between rs671 and rs3782886) (Additional file  1: Figure 
S1). To identify the type of pleiotropy, adjusted associa-
tion analyses were repeatedly performed across the eight 
cardio-metabolic traits. Mediated analyses showed that 
the association between rs671 and the three lipid traits 
(TG, HDL and LDL) remained significant after adjust-
ments for all other cardio-metabolic traits (Table  3; 
Fig. 3; Additional file 1: Table S5). In addition, the associ-
ation between rs671 and FPG, SBP, DBP, BMI and WHR 
remained significant after adjustments for the three lipid 
traits, suggesting that rs671 on ALDH2 is independently 
associated with each cardio-metabolic trait (Table  3; 
Fig. 3; Additional file 1: Table S5). The adjusted associa-
tions of rs3782886 and rs11066015 with each cardio-met-
abolic trait showed the same effects as rs671 (data not 
shown).
Protein–protein interactions
To assess the physical interactions among the three 
pleiotropic genes in the 12q24.12 region, protein–pro-
tein interactions were tested using the Wiki-Pi database 
(http://severus.dbmi.pitt.edu/wiki-pi/) [22]. There were 
numerous direct protein–protein interactions for the 
three genes: 12 interactions for ALDH2, one interaction 
Fig. 1 Overlap of loci associated with different lipids. This Venn diagram illustrates the name of lipid‑associated loci that replicated in our study 
(P < 3.70 × 10−4)
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Table 1 Results of meta-analyses for associations between lipid loci and cardio-metabolic traits
A threshold of association significance after correction for multiple testing is P < 3.70 × 10−4
CHR chromosome, A1/A2 minor allele/major allele, MAF minor allele frequency, n number of participants, SBP systolic blood pressure, DBP diastolic blood pressure, 
FPG fasting plasma glucose, HbA1c Glycated hemoglobin, BMI body mass index, WHR waist-hip ratio; All of analyses were adjusted by age and sex. s.e. standard error, 
Pcombined P value from meta-analyses using the results from three cohorts, Phet P value from test of heterogeneity, Q Cochrane’s Q value based on Chi squared statistics





FPG 2 rs780093 27742603 GCKR Intronic G/A 0.456 0.73 ± 0.13 6.26 × 10−9 0.72 (0.64)
11 rs174547 61570783 FADS1 Intronic G/A 0.319 −0.70 ± 0.13 1.71 × 10−7 0.94 (0.12)
11 rs174570 61597212 FADS2 Intronic A/G 0.319 −0.71 ± 0.13 1.09 × 10−7 0.97 (0.07)
12 rs3782886 112110489 BRAP Nonsynonymous G/A 0.167 −0.90 ± 0.17 7.21 × 10−8 0.67 (0.79)
12 rs11066015 112168009 ACAD10 Intronic A/G 0.158 −0.92 ± 0.17 5.93 × 10−8 0.74 (0.60)
12 rs671 112241766 ALDH2 Nonsynonymous A/G 0.157 −0.96 ± 0.17 2.00 × 10−8 0.80 (0.44)
HbA1c 6 rs1799945 26091179 HFE Nonsynonymous G/C 0.045 −0.06 ± 0.01 4.57 × 10−5 –
Blood pressure 
(n = 10,310)
SBP 12 rs3782886 112110489 BRAP Nonsynonymous G/A 0.167 −1.34 ± 0.31 1.50 × 10−5 0.04 (4.15)
12 rs11066015 112168009 ACAD10 Intronic A/G 0.158 −1.53 ± 0.32 1.33 × 10−6 0.03 (4.50)
12 rs671 112241766 ALDH2 Nonsynonymous A/G 0.157 −1.49 ± 0.32 2.72 × 10−6 0.05 (4.01)
DBP 12 rs3782886 112110489 BRAP Nonsynonymous G/A 0.167 −0.78 ± 0.20 1.02 × 10−4 0.49 (0.48)
12 rs11066015 112168009 ACAD10 Intronic A/G 0.158 −0.82 ± 0.21 7.12 × 10−5 0.41 (0.67)
12 rs671 112241766 ALDH2 Nonsynonymous A/G 0.157 −0.80 ± 0.21 1.09 × 10−4 0.47 (0.52)
Obesity 
(n = 13,378)
BMI 16 rs1421085 53800954 FTO Intronic G/A 0.125 0.29 ± 0.06 1.84 × 10−7 0.70 (0.71)
WHR 5 rs3846662 74651084 HMGCR Intronic A/G 0.476 0.003 ± 0.001 3.69 × 10−4 0.29 (2.45)
12 rs3782886 112110489 BRAP Nonsynonymous G/A 0.167 −0.004 ± 0.001 3.45 × 10−5 0.12 (4.32)
12 rs11066015 112168009 ACAD10 Intronic A/G 0.158 −0.005 ± 0.001 3.35 × 10−6 0.13 (4.14)
12 rs671 112241766 ALDH2 Nonsynonymous A/G 0.157 −0.005 ± 0.001 2.87 × 10−6 0.13 (4.10)
Fig. 2 Summary of meta‑analyses for associations between previously implicated lipid loci and cardio‑metabolic traits. There are genes and genetic 
loci on chromosomes associated with cardio‑metabolic traits that reached the statistical significance (P < 3.70 × 10−4) after correction for multiple 
testing in this study
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for ACAD10 and 15 interactions for BRAP. According 
to this analysis, the three pleiotropic genes were func-
tionally connected by one gene, APP, which encodes 
amyloid beta (A4) precursor protein (Additional file  1: 
Figure S2). This protein participated in several biologi-
cal pathways and showed 1995 interactions with other 
proteins within Wiki-Pi data (Additional file  1: Table 
S6). In particular, APP has a role in the cholesterol 
metabolic process and in blood coagulation (Additional 
file 1: Table S6).
Associations between lipid risk scores and other 
cardio‑metabolic traits
To examine the cumulative genetic effect of the 49 rep-
licated lipid SNPs on other cardio-metabolic traits such 
as FPG, SBP, DBP, BMI and WHR, a lipid risk score was 
calculated for TG, TC, HDL and LDL from different sets 
of SNPs, and two types of lipid risk score were calcu-
lated for each lipid. The weighted risk score for LDL was 
associated with all five cardio-metabolic traits (P < 0.05) 
(Table 4). The unweighted risk score of the four lipids was 
associated with FPG (P < 0.05) (Table 4).
Discussion
In this study, we performed meta-analyses of associa-
tions between 135 SNPs and 10 cardio-metabolic traits 
using Exome chip data from 14,028 Korean individuals 
to assess whether lipid-associated loci reported by the 
Global Lipids Genetics Consortium are also applicable to 
cardio-metabolic traits in this population. The 49 SNPs 
out of 135 SNPs that located lipid-associated loci were 
significantly replicated in these Korean participants after 
correction for multiple testing. Eighteen SNPs showed 
substantial pleiotropic effects on other cardio-metabolic 
traits that are risk factors for cardiovascular disease, such 
as lipids. We also reported a major pleiotropic effect of 
three genes in the 12q24.12 region on cardio-metabolic 
traits and confirmed the relevance of independent pleio-
tropic effect. Independent pleiotropy can occur at the 
regional level, whereby multiple variants in the same 
region are associated with different traits [10]. The 
physiological interrelation among these three genes was 
revealed by protein–protein interactions. They were con-
nected by a mediator gene, APP, that participates in the 
lipid metabolic process [23].
At the 12q24.12 pleiotropic region, the functional non-
synonymous variant rs671 on ALDH2 which encodes 
the aldehyde dehydrogenase 2 family, has been reported 
to be associated with coronary artery diseases, blood 
pressure and alcohol consumption and is common in 
East-Asian populations in contrast to monomorphic 
in Europeans [7, 24]. One previous study provided evi-
dence of positive selection at 12q24.12 by confirming the 
occurrence of a selective sweep in East-Asians by haplo-
type-based tests [7]. We predicted the functional effects, 
possibly damaging, potentially disease-causing biologi-
cal effects, of the missense mutation at SNP rs671 using 
PolyPhen 2 and SIFT programs [25, 26]. In the current 
study, we established the genetic overlap of rs671 across 
eight cardio-metabolic traits, and first reported the 
Table 2 Pleiotropic effects of three SNPs located in the 12q24.12 region
n number of participants, s.e. standard error, TG Triglyceride, TC Total cholesterol, LDL Low density lipoprotein cholesterol, HDL high density lipoprotein cholesterol, 
SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, HbA1c Glycated hemoglobin, BMI body mass index, WHR waist-hip ratio
All of analyses were adjusted by age and sex
Traits n rs671, ALDH2 rs11066015, ACAD10 rs3782886, BRAP
Effect size (beta ± s.e.) P Effect size (beta ± s.e.) P Effect size (beta ± s.e.) P
Lipids
 TC 13,378 −0.03 ± 0.59 0.9547 −0.03 ± 0.59 0.9633 −0.26 ± 0.58 0.6502
 TG 13,378 −7.60 ± 1.72 9.47 × 10−6 −7.28 ± 1.71 2.11 × 10−5 −6.93 ± 1.68 3.53 × 10−5
 LDL 13,378 2.55 ± 0.53 1.53 × 10−6 2.54 ± 0.53 1.50 × 10−6 2.13 ± 0.52 3.80 × 10−5
 HDL 13,378 −1.33 ± 0.18 1.20 × 10−13 −1.33 ± 0.18 7.61 × 10−14 −1.33 ± 0.17 2.97 × 10−14
Blood pressure
 SBP 10,310 −1.49 ± 0.32 2.72 × 10−6 −1.53 ± 0.32 1.33 × 10−6 −1.34 ± 0.31 1.50 × 10−5
 DBP 10,310 −0.80 ± 0.21 1.09 × 10−4 −0.82 ± 0.21 7.12 × 10−5 −0.78 ± 0.20 1.02 × 10−4
Glycemic traits
 FPG 13,378 −0.96 ± 0.17 2.00 × 10−8 −0.92 ± 0.17 5.93 × 10−8 −0.90 ± 0.17 7.21 × 10−8
 HbA1c 7524 0.003 ± 0.008 0.6858 0.006 ± 0.008 0.4870 0.004 ± 0.008 0.5924
Obesity
 BMI 13,378 −0.16 ± 0.05 2.14 × 10−3 −0.16 ± 0.05 2.10 × 10−3 −0.13 ± 0.05 1.06 × 10−2
 WHR 13,378 −0.005 ± 0.001 2.87 × 10−6 −0.005 ± 0.001 3.35 × 10−6 −0.004 ± 0.001 3.45 × 10−5
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association between this locus and FPG with genome-
wide significance.
Two other SNPs in linkage disequilibrium (r2  >  0.9) 
with rs671 in Koreans, rs3782886 and rs11066015, 
showed the same genetic effects as rs671. Rs3782886 
is a non-synonymous variant located on BRAP, which 
encodes BRCA1-associated protein, and rs11066015 is 
an intronic variant on ACAD10, which encodes acyl-CoA 
dehydrogenase family member 10. Previous studies have 
reported that ACAD10 is associated with coronary artery 
disease and T2D, and it has been suggested that the effect 
of ACAD10 on T2D might be mediated by disordered 
insulin resistance that is due to abnormal lipid oxidation 
[27, 28]. The two SNPs rs3782886 and rs11066015 were 
polymorphic only in individuals of East-Asian descent. 
This suggests that the pleiotropic associations described 
in our study may be specific to East-Asian individuals.
The three genes in the 12q24.12 region, ALDH2, BRAP 
and ACAD10, were functionally linked by a media-
tor gene, APP, that takes part in lipid-related metabolic 
processes (MIM104760). APP is a complex biological 
molecule that interacts with many types of receptors or 
proteins [29]. Mutations in APP have been implicated in 
Alzheimer’s disease and cerebroarterial amyloidosis [30]. 
Alzheimer’s disease is believed to be driven by the accu-
mulation and deposition of the amyloid beta precursor 
protein that encoded by APP in brain region [23]. The 
abnormal accumulation or clearance of the amyloid beta 
precursor protein is regulated by cholesterol levels [23]. 
High LDL and low HDL is commonly found in patients 
with CVD and it has been shown to correlate with an 
increased risk of Alzheimer’s disease, with high risk 
being associated with advanced CVD [31]. As the three 
genes in 12q24.12 region is well known to association 
with CVD and lipid metabolism, the functional relation 
between APP and three genes in our study newly suggests 
that APP might play an important role in modulating 
CVD and dyslipidemia as well as Alzheimer’s disease.
An additional investigation was performed to reveal 
the combined genetic effect of lipid SNPs on other car-
dio-metabolic traits. This was conducted using lipid 
risk scores calculated by combination of the lipid SNPs 
implicated in this study. We were able to detect signifi-
cant associations between unweighted or weighted lipid 
risk scores and cardio-metabolic traits. All four of the 
unweighted lipid risk scores were significantly associated 
with FPG. This provides compelling evidence that lipid 
risk SNPs have the potential to be used for identification 
of T2D risk. The finding that unweighted and weighted 
HDL risk scores were associated with SBP and DBP also 
suggests a shared genetic background between these 
traits. Our results showing an association between lipid 
risk scores and cardio-metabolic traits require replication 
in other ethnic groups.
Future directions
In this study, we have presented lipid-related genetic var-
iants with pleiotropic effects on other cardio-metabolic 
traits. Recent studies suggested that pleiotropic effects 
on complex traits may be widespread. Genetic variants 
associated with two or more traits, such as rs7138803 
on FAIM2 that related to obesity, T2D and myocardial 
infarction, rs8192673 on PGC-1α and rs1801282 on 
PPAR-γ associated with waist circumference and T2D, 
were revealed by previous studies [32–34]. The increased 
use of genetic information in clinical practice, has under-
scored the importance of understanding pleiotropy and 
its implications for genetic testing and personal genom-
ics. A gene or multiple genes in a biological pathway 
that affect more than one trait present new chances and 
Fig. 3 Pleiotropic effects on three genes (BRAP, ACAD10 and ALDH2) in the 12q24.12 region. This region was associated independently with each 
cardio‑metabolic trait according to additional analyses including adjustments. The black arrows represented the direction of genetic effects on each 
trait
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challenges for drug development. However, most stud-
ies have focused only on the detection of pleiotropic 
effects. Functionally characterizing identified variants 
through experiments and understanding the mechanisms 
of shared pathophysiology are necessary to establish 
causality. In addition, gene-environmental interactions 
(G ×  E) could provide insights the role of environmen-
tal factors in disease risk and hence to investigate their 
role as genetic factor modifiers [35]. For example, rs671 
on ALDH2 was found to be associated with TG when 
the interaction between SNP and alcohol consumption 
was considered [36]. By integrating biological knowledge 
with genetic pleiotropy and environmental factors, G × E 
interactions may provide the potential to shed light on 
biological processes leading to diseases and could explain 
‘missing heritability’ for phenotypic variance in GWASs. 
And also, it may be necessary to search for additional 
shared genetic patterns on multiple phenotypes in larger 
sample sizes across diverse ethnic cohorts as well as 
Korean population.
Conclusions
In summary, our results provide evidence that lipid-
related loci implicated by previous GWASs also affect 
other cardio-metabolic traits in Korean individuals. 
We identified SNPs in the 12q24.12 region with ethnic-
specific independent pleiotropic effects on both lipids 
and one or more metabolic traits. Our results may help 
to elucidate the East-Asian specific shared genetic back-
ground for cardio-metabolic traits that affect the risk of 
cardiovascular disease.
Authors’ contributions
YKK provided the study design and performed data analysis, writing and 
editing manuscript. MYH, YJK and SH participated in data analysis, SM and BJK 
participated in general discussion, reviewed data and editing manuscript. All 
authors read and approved the final manuscript.
Acknowledgements
This work was supported by an intramural grant from the Korea National Insti‑
tute of Health (2012‑N73002‑00, 2014‑NI73001‑00) and grants from the Korea 
Centers for Disease Control and Prevention (4845‑301, 4851‑302, 4851‑307).
Competing interests
The authors declare that they have no competing interests.
Additional file
Additional file 1: Figure S1. The direction of the allelic effect for each 
of three pleiotropic SNPs in the 12q24.12 region. Figure S2. Protein‑
protein interactions among three genes in the 12q24.12 region. Table 
S1. Frequency distribution of minor allele frequencies in Exome chip data. 
Table S2. Descriptive information of study subjects. Table S3. Replication 
results of known lipid‑associated loci in Korean individuals. Table S4. 
Population diversity of three pleiotropic SNPs in the 12q24.12 region. 
Table S5. Evaluation of pleiotropic effect of 12q24.12 (ALDH2, rs671) 
genotypes. Table S6. Protein‑protein interactions among three genes in 
12q24.12 region. 
Received: 16 October 2015   Accepted: 14 January 2016
References
 1. Dauriz M, Meigs JB. Current insights into the joint genetic basis of 
type 2 diabetes and coronary heart disease. Cur Cardiovasc Risk Rep. 
2014;8(1):368.
 2. O’Donnell CJ, Elosua R. Cardiovascular risk factors. Insights from Framing‑
ham Heart Study. Rev Esp Cardiol. 2008;61(3):299–310.
 3. Riserus U, Arnlov J, Berglund L. Long‑term predictors of insulin resistance: 
role of lifestyle and metabolic factors in middle‑aged men. Diabetes Care. 
2007;30(11):2928–33.
 4. Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer 
AR, Macfarlane PW, McKillop JH, et al. Pravastatin and the development of 
diabetes mellitus: evidence for a protective treatment effect in the West 
of Scotland Coronary Prevention Study. Circulation. 2001;103(3):357–62.
 5. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, 
Ganna A, Chen J, Buchkovich ML, Mora S, et al. Discovery and refinement 
of loci associated with lipid levels. Nat Genet. 2013;45(11):1274–83.
 6. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, 
Smith AV, Tobin MD, Verwoert GC, Hwang SJ, et al. Genetic variants in 
novel pathways influence blood pressure and cardiovascular disease risk. 
Nature. 2011;478(7367):103–9.
 7. Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X, Tay WT, Chen CH, 
Zhang Y, Yamamoto K, et al. Meta‑analysis of genome‑wide association 
studies identifies common variants associated with blood pressure varia‑
tion in east Asians. Nat Genet. 2011;43(6):531–8.
 8. Rankinen T, Sarzynski MA, Ghosh S, Bouchard C. Are there genetic paths 
common to obesity, cardiovascular disease outcomes, and cardiovascular 
risk factors? Circ Res. 2015;116(5):909–22.
 9. Ligthart S, de Vries PS, Uitterlinden AG, Hofman A, Franco OH, Chasman DI, 
Dehghan A. Pleiotropy among common genetic loci identified for cardio‑
metabolic disorders and C‑reactive protein. PLoS One. 2015;10(3):e0118859.
 10. Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in com‑
plex traits: challenges and strategies. Nat Rev Genet. 2013;14(7):483–95.
 11. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, 
Park M, et al. A large‑scale genome‑wide association study of Asian 
populations uncovers genetic factors influencing eight quantitative traits. 
Nat Genet. 2009;41(5):527–34.
 12. Kim YJ, Go MJ, Hu C, Hong CB, Kim YK, Lee JY, Hwang JY, Oh JH, Kim DJ, Kim 
NH, et al. Large‑scale genome‑wide association studies in East Asians identify 
new genetic loci influencing metabolic traits. Nat Genet. 2011;43(10):990–5.
 13. Hwang JY, Sim X, Wu Y, Liang J, Tabara Y, Hu C, Hara K, Tam CH, Cai Q, 
Zhao Q, et al. Genome‑wide association meta‑analysis identifies novel 
variants associated with fasting plasma glucose in East Asians. Diabetes. 
2015;64(1):291–8.
 14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration 
of low‑density lipoprotein cholesterol in plasma, without use of the 
preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
 15. Grove ML, Yu B, Cochran BJ, Haritunians T, Bis JC, Taylor KD, Hansen M, 
Borecki IB, Cupples LA, Fornage M, et al. Best practices and joint calling 
of the HumanExome BeadChip: the CHARGE Consortium. PLoS One. 
2013;8(7):e68095.
 16. Peloso GM, Auer PL, Bis JC, Voorman A, Morrison AC, Stitziel NO, Brody JA, 
Khetarpal SA, Crosby JR, Fornage M, et al. Association of low‑frequency 
and rare coding‑sequence variants with blood lipids and coronary heart 
disease in 56,000 whites and blacks. Am J Hum Genet. 2014;94(2):223–32.
 17. Huyghe JR, Jackson AU, Fogarty MP, Buchkovich ML, Stancakova A, String‑
ham HM, Sim X, Yang L, Fuchsberger C, Cederberg H, et al. Exome array 
analysis identifies new loci and low‑frequency variants influencing insulin 
processing and secretion. Nat Genet. 2013;45(2):197–201.
 18. Guo Y, He J, Zhao S, Wu H, Zhong X, Sheng Q, Samuels DC, Shyr Y, Long J. 
Illumina human exome genotyping array clustering and quality control. 
Nat Protoc. 2014;9(11):2643–62.
 19. Li N, van der Sijde MR, Bakker SJ, Dullaart RP, van der Harst P, Gansevoort 
RT, Elbers CC, Wijmenga C, Snieder H, Hofker MH, et al. Pleiotropic effects 
of lipid genes on plasma glucose, HbA1c, and HOMA‑IR levels. Diabetes. 
2014;63(9):3149–58.
Page 11 of 11Kim et al. Cardiovasc Diabetol  (2016) 15:20 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 20. Purcell S, Neale B, Todd‑Brown K, Thomas L, Ferreira MA, Bender D, Maller 
J, Sklar P, de Bakker PI, Daly MJ, et al. PLINK: a tool set for whole‑genome 
association and population‑based linkage analyses. Am J Hum Genet. 
2007;81(3):559–75.
 21. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta‑analysis of 
genomewide association scans. Bioinformatics. 2010;26(17):2190–1.
 22. Orii N, Ganapathiraju MK. Wiki‑pi: a web‑server of annotated human 
protein‑protein interactions to aid in discovery of protein function. PLoS 
One. 2012;7(11):e49029.
 23. Puglielli L, Tanzi RE, Kovacs DM. Alzheimer’s disease: the cholesterol con‑
nection. Nat Neurosci. 2003;6(4):345–51.
 24. Takeuchi F, Isono M, Nabika T, Katsuya T, Sugiyama T, Yamaguchi S, Kob‑
ayashi S, Ogihara T, Yamori Y, Fujioka A, et al. Confirmation of ALDH2 as a 
Major locus of drinking behavior and of its variants regulating multiple 
metabolic phenotypes in a Japanese population. Circ J. 2011;75(4):911–8.
 25. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, 
Kondrashov AS, Sunyaev SR. A method and server for predicting damag‑
ing missense mutations. Nat Methods. 2010;7(4):248–9.
 26. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non‑synony‑
mous variants on protein function using the SIFT algorithm. Nat Protoc. 
2009;4(7):1073–81.
 27. Lee JY, Lee BS, Shin DJ, Woo Park K, Shin YA, Joong Kim K, Heo L, Young 
Lee J, Kyoung Kim Y, Jin Kim Y, et al. A genome‑wide association study of 
a coronary artery disease risk variant. J Hum Genet. 2013;58(3):120–6.
 28. Bian L, Hanson RL, Muller YL, Ma L, Kobes S, Knowler WC, Bogardus 
C, Baier LJ. Variants in ACAD10 are associated with type 2 diabetes, 
insulin resistance and lipid oxidation in Pima Indians. Diabetologia. 
2010;53(7):1349–53.
 29. Sadigh‑Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, 
Mahmoudi J. Amyloid‑beta: a crucial factor in Alzheimer’s disease. Med 
Princ Pract. 2015;24(1):1–10.
 30. Conidi ME, Bernardi L, Puccio G, Smirne N, Muraca MG, Curcio SA, Colao 
R, Piscopo P, Gallo M, Anfossi M, et al. Homozygous carriers of APP A713T 
mutation in an autosomal dominant Alzheimer disease family. Neurology. 
2015;84(22):2266–73.
 31. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van 
Duijn CN, Van Broeckhoven C, Grobbee DE. Atherosclerosis, apolipo‑
protein E, and prevalence of dementia and Alzheimer’s disease in the 
Rotterdam Study. Lancet. 1997;349(9046):151–4.
 32. Corella D, Sorli JV, Gonzalez JI, Ortega C, Fito M, Bullo M, Martinez‑Gon‑
zalez MA, Ros E, Aros F, Lapetra J, et al. Novel association of the obesity 
risk‑allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with 
heart rate and study of its effects on myocardial infarction in diabetic 
participants of the PREDIMED trial. Cardiovasc Diabetol. 2014;13:5.
 33. Kruzliak P, Haley AP, Starcevic JN, Gaspar L, Petrovic D. Polymorphisms 
of the peroxisome proliferator‑activated receptor‑gamma (rs1801282) 
and its coactivator‑1 (rs8192673) are associated with obesity indexes in 
subjects with type 2 diabetes mellitus. Cardiovasc Diabetol. 2015;14:42.
 34. Adams JN, Raffield LM, Freedman BI, Langefeld CD, Ng MC, Carr JJ, Cox AJ, 
Bowden DW. Analysis of common and coding variants with cardiovascu‑
lar disease in the Diabetes Heart Study. Cardiovasc Diabetol. 2014;13:77.
 35. Thomas D. Gene‑environment‑wide association studies: emerging 
approaches. Nat Rev Genet. 2010;11(4):259–72.
 36. Tan A, Sun J, Xia N, Qin X, Hu Y, Zhang S, Tao S, Gao Y, Yang X, Zhang H, 
et al. A genome‑wide association and gene‑environment interaction 
study for serum triglycerides levels in a healthy Chinese male population. 
Hum Mol Genet. 2012;21(7):1658–64.
